-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cara Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
- Cara Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$12.5M, a 55.5% increase year-over-year.
- Cara Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$95.5M, a 18% increase year-over-year.
- Cara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$119M, a 38.7% decline from 2022.
- Cara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$85.5M, a 3.36% increase from 2021.
- Cara Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$88.4M, a 1152% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)